Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial <i>Helicobacter pylori</i> Treatment: A Randomized Trial

Abstract

First-line tailored therapy achieves significantly higher eradication rates and fewer side effects, compared to triple therapy plus bismuth and concomitant therapy in a setting with high rates of clarithromycin and metronidazole resistance.